Developing New Therapies
for Diseases with Significant
Unmet Medical Needs
Vitae Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing novel, small molecule drugs for diseases with significant unmet medical needs.The company leverages its structure-based drug design platform, Contour®, creating a robust and growing portfolio of product candidates.
Vitae Pharmaceuticals is developing and plans to commercialize multiple product candidates including its innovative RORγt program to treat various autoimmune diseases.
Vitae Pharmaceuticals has developed proprietary expertise in structure-based drug design (SBDD). The clinical stage biopharmaceutical company utilizes its Contour® SBDD platform to discover drugs for validated therapeutic targets against which the industry has struggled due to challenges related to potency, selectivity, pharmacokinetics, or patentability. This gives Vitae’s scientists the ability to create first-in-class or best-in-class drugs for targets that are “difficult-to-drug.”